Wolters Kluwer and The Journal of Bone and Joint Surgery, Inc. Announce JBJS Open Access


Newswise — October 6, 2016 – Wolters Kluwer, a leading global provider of information and point of care solutions for the healthcare industry, in partnership with the Editorial Board and Board of Trustees of the Journal of Bone and Joint Surgery, Inc., is pleased to announce the launch of the new open access journal, JBJS Open Access. The journal, now open for article submissions, is the sixth journal of the renowned Journal of Bone and Joint Surgery, Inc. portfolio that already includes its chief journal, The Journal of Bone & Joint Surgery, as well as JBJS Essential Surgical Techniques, JBJS Case Connecter, JBJS Reviews, and JBJS Journal of Orthopaedics for Physician Assistants.

JBJS Open Access is an international, peer-reviewed, online-only journal that will publish basic-science and clinical findings as well as new research approaches that have the potential of impacting musculoskeletal disease and injury care worldwide. As an open access publication, all articles published in the journal are available for anyone across the world to read free of charge.

"With the launch of JBJS Open Access Wolters Kluwer remains focused on expanding the premier reputation and influence JBJS demonstrates within the orthopaedics specialty,” said Jayne Marks, Vice President, Global Publishing for Wolters Kluwer, Health Learning, Research & Practice.

An independent, non-profit publisher, JBJS produces print and online journals and learning products. The flagship journal, The Journal of Bone & Joint Surgery, traces its origins back to the 1889 Transactions of the American Orthopedic Association, and is the gold standard in peer-reviewed scientific information in orthopaedics. JBJS Inc. is also an accredited provider of Continuing Medical Education (CME) and produces online CME activities.

JBJS is excited to be able to offer JBJS Open Access as one more step in our continuing effort to meet our authors’ and readers’ evolving needs,” wrote Marc Swiontkowski, MD, the Editor-in-Chief of JBJS in an Editorial published July 6th, 2016. “We are proud that authors will now have an open access publication option while receiving the outstanding services and brand of excellence that JBJS has been providing its authors for over 125 years—and that a wider audience of readers will have access to the best in orthopaedics information.”

JBJS Open Access manuscripts will undergo the same rigorous peer review for which JBJS is known. Contributions from anywhere in the world are welcome. Authors and reviewers will have access to an enhanced and streamlined electronic manuscript submission, review, and tracking process. To learn more visit http://www.editorialmanager.com/jbjsoa.

###

About JBJSJBJS, Inc., is a not-for-profit publisher specializing in orthopaedic information. It publishes The Journal of Bone & Joint Surgery, which has been the most valued source of information for orthopaedic surgeons and researchers for over 125 years and is the gold standard in peer-reviewed scientific information in the field – a core journal and essential reading for orthopaedic surgeons worldwide. Other publications include JBJS Reviews, JBJS Case Connector and JBJS Essential Surgical Techniques, along with CME and professional development products. Twitter: @jbjs.

About Wolters KluwerWolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.

Wolters Kluwer reported 2015 annual revenues of €4.2 billion. The group serves customers in over 180 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY). Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and organization, visit www.wolterskluwer.com, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.


Comment/Share

Chat now!
5.3713